Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Randi Hagerman

Showing results (151-160 of 159) with videos related to

Pageof 16
Sort By:
You have reached the last page of results.This site can display upto 159 results.
Frontiers in Psychiatry|December 3, 2021
EEG Signal Complexity Is Reduced During Resting-State in Fragile X SyndromeMélodie Proteau-Lemieux, Inga Sophia Knoth, Kristian Agbogba, et al.
Cells|July 29, 2023
Intercorrelation of Molecular Biomarkers and Clinical Phenotype Measures in Fragile X SyndromeRamkumar Aishworiya, Mei-Hung Chi, Marwa Zafarullah, et al.
Frontiers in Psychiatry|March 14, 2022
Corrigendum: EEG Signal Complexity Is Reduced During Resting-State in Fragile X SyndromeMélodie Proteau-Lemieux, Inga Sophia Knoth, Kristian Agbogba, et al.
Brain Pathology (Zurich, Switzerland)|September 13, 2021
Hispano-American Brain Bank on Neurodevelopmental Disorders: An initiative to promote brain banking, research, education, and outreach in the field of neurodevelopmental disordersBrett D Dufour, Lilia Albores-Gallo, Jose Luna-Muñoz, et al.
Molecular Genetics & Genomic Medicine|July 19, 2022
Descriptive analysis of seizures and comorbidities associated with fragile X syndromeIgor Albizua, Krista Charen, Lisa Shubeck, et al.
Cells|December 22, 2023
Open-Label Sulforaphane Trial in FMR1 Premutation Carriers with Fragile-X-Associated Tremor and Ataxia Syndrome (FXTAS)Ellery Santos, Courtney Clark, Hazel Maridith B Biag, et al.
Nature Reviews. Drug Discovery|December 9, 2017
Drug development for neurodevelopmental disorders: lessons learned from fragile X syndromeElizabeth M Berry-Kravis, Lothar Lindemann, Aia E Jønch, et al.
SAGE Open Medicine|November 1, 2024
Negative effect of treatment with mGluR5 negative allosteric modulator AFQ056 on blood biomarkers in young individuals with Fragile X syndromeDragana Protic, Elizabeth Breeze, Guadalupe Mendoza, et al.
The Journal of Clinical Investigation|August 31, 2023
Effects of AFQ056 on language learning in fragile X syndromeElizabeth Berry-Kravis, Leonard Abbeduto, Randi Hagerman, et al.
Pageof 16

Showing results (151-160 of 159) with videos related to

Sort By:
Pageof 16
You have reached the last page of results.This site can display upto 159 results.
Frontiers in Psychiatry|December 3, 2021
EEG Signal Complexity Is Reduced During Resting-State in Fragile X SyndromeMélodie Proteau-Lemieux, Inga Sophia Knoth, Kristian Agbogba, et al.
Cells|July 29, 2023
Intercorrelation of Molecular Biomarkers and Clinical Phenotype Measures in Fragile X SyndromeRamkumar Aishworiya, Mei-Hung Chi, Marwa Zafarullah, et al.
Frontiers in Psychiatry|March 14, 2022
Corrigendum: EEG Signal Complexity Is Reduced During Resting-State in Fragile X SyndromeMélodie Proteau-Lemieux, Inga Sophia Knoth, Kristian Agbogba, et al.
Brain Pathology (Zurich, Switzerland)|September 13, 2021
Hispano-American Brain Bank on Neurodevelopmental Disorders: An initiative to promote brain banking, research, education, and outreach in the field of neurodevelopmental disordersBrett D Dufour, Lilia Albores-Gallo, Jose Luna-Muñoz, et al.
Molecular Genetics & Genomic Medicine|July 19, 2022
Descriptive analysis of seizures and comorbidities associated with fragile X syndromeIgor Albizua, Krista Charen, Lisa Shubeck, et al.
Cells|December 22, 2023
Open-Label Sulforaphane Trial in FMR1 Premutation Carriers with Fragile-X-Associated Tremor and Ataxia Syndrome (FXTAS)Ellery Santos, Courtney Clark, Hazel Maridith B Biag, et al.
Nature Reviews. Drug Discovery|December 9, 2017
Drug development for neurodevelopmental disorders: lessons learned from fragile X syndromeElizabeth M Berry-Kravis, Lothar Lindemann, Aia E Jønch, et al.
SAGE Open Medicine|November 1, 2024
Negative effect of treatment with mGluR5 negative allosteric modulator AFQ056 on blood biomarkers in young individuals with Fragile X syndromeDragana Protic, Elizabeth Breeze, Guadalupe Mendoza, et al.
The Journal of Clinical Investigation|August 31, 2023
Effects of AFQ056 on language learning in fragile X syndromeElizabeth Berry-Kravis, Leonard Abbeduto, Randi Hagerman, et al.
Pageof 16